Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection

Clinical Therapeutics

Volumn 21, Issue 11, 1999, Pages 1864-1872

  Stein, Gary E ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Cystitis; Fosfomycin; Nitrofurantoin; Urinary tract infection

Indexed keywords

FOSFOMYCIN; FOSFOMYCIN TROMETAMOL; NITROFURANTOIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; URINARY TRACT INFECTION; VAGINITIS;

EID: 0032796432     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)86734-X     Document Type: Article

References (19)

1. 1. Ronald A, Nicolle LE, Harding G. Single dose treatment failure in women with acute cystitis. Infection. 1992;20(Suppl 4):S276-S279.
2. 2. Hatton J, Hughes M, Raymond CH. Management of bacterial urinary tract infections in adults. Ann Pharmacother. 1994; 28:1264-1272.
3. 3. Naber KG. Uncomplicated urinary tract infections - is single-dose therapy effective? Int J Antimicrob Agents. 1994;4(Suppl 2):S39-S45.
4. 4. Stamm WE. Controversies in single dose therapy of acute uncomplicated urinary tract infections in women. Infection. 1992;20(Suppl 4):S272-S275.
5. 5. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999;281:736-738.
6. 6. Reeves DS. Clinical efficacy and safety of fosfomycin trometamol in the prevention and treatment of urinary tract infections. Rev Contemp Pharmacother. 1995;6:71-83.
7. 7. Reeves DS, Holt HA, Bywater MJ. In vitro study of fosfomycin trometamol. In: Neu HC, Williams JD, eds. New Trends in Urinary Tract Infections. Basel, Switzerland: Karger; 1988:224-233.
8. 8. Greenwood D, Edwards R, Brown J, Ridout P. The comparative activity of fosfomycin trometamol against organisms isolated from infected urines. Infection. 1992;20(Suppl 4):S302-S304.
9. 9. Bergan T. Pharmacokinetics of fosfomycin. Rev Contemp Pharmacother. 1995;6: 55-62.
10. 10. Naber KG, Johnson FN. The safety and tolerability of fosfomycin trometamol. Rev Contemp Pharmacother. 1995;6:63-70.
11. 11. Pfaller MA, Barry AL, Fuchs PC. Evaluation of disk susceptibility testing of fosfomycin tromethamine. Diagn Microbiol Infect Dis. 1993;17:67-70.
12. 12. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328-1334.
13. 13. The Inter-Nordic Urinary Tract Infection Study Group. Double-blind comparison of 3-day versus 7-day treatment with norfloxacin in symptomatic urinary tract infections. Scand J Infect Dis. 1988;20:619-624.
14. 14. Norrby SR. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev Infect Dis. 1990;12:458-467.
15. 15. Naber KG. Fosfomycin trometamol in treatment of uncomplicated lower urinary tract infections in adult women-an overview. Infection. 1992;20(Suppl 4):S310-S312.
16. 16. VanPienbroek E, Hermans J, Kapstein AA, Mulder JD. Fosfomycin trometamol in a single dose versus seven days of nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women. Pharm World Sci. 1993;15:257-262.
17. 17. Fihn SD, Johnson G, Roberts PL, et al. Trimethoprim-sulfamethoxazole for acute dysuria in women: A single-dose or 10-day course. Ann Intern Med. 1988;108:350-357.
18. 18. Stein GE. Single-dose treatment of acute cystitis with fosfomycin tromethamine. Ann Pharmacother. 1998;32:215-219.
19. 19. Zhanel GG, Ronald AR. Single-dose versus traditional therapy for uncomplicated urinary tract infections. Drug Intell Clin Pharm. 1988;22:21-24.